Clough Capital

Amphivena raises $62M Series C round to develop bispecific antibody in solid tumors

The company presented data from a Phase I study in acute myeloid leukemia at the European Hematology Association's annual meeting during the summer.

By Alaric DeArment

Unlocking Transparency in PBM Pricing

The TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development.

Physician Targeting Using Real-time Data: How PurpleLab’s Alerts Can Help

By leveraging real-time data that offers unprecedented insights into physician behavior and patient outcomes, companies can gain a competitive advantage with prescribers. PurpleLab®, a healthcare analytics platform with one of the largest medical and pharmaceutical claims databases in the United States, recently announced the launch of Alerts which translates complex information into actionable insights, empowering companies to identify the right physicians to target, determine the most effective marketing strategies and ultimately improve patient care.

By PurpleLab